Thompson Siegel & Walmsley LLC Bausch Health Companies Inc. Transaction History

Thompson Siegel & Walmsley LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$21.6 - $27.79 $864 - $1,111	-40 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$23.0 - $29.01 $15.2 Million - $19.2 Million	-660,370 Reduced 99.99%	40 $1,000
Q3 2021 Nov 05, 2021	SELL	$25.04 - $30.06 $21.6 Million - $26 Million	-863,744 Reduced 56.67%	660,410 $18.4 Million
Q2 2021 Aug 09, 2021	BUY	$27.43 - $32.7 $4.06 Million - $4.84 Million	148,070 Added 10.76%	1,524,154 $44.7 Million
Q1 2021 May 07, 2021	BUY	$21.37 - $34.38 $29.4 Million - $47.3 Million	1,376,084 New	1,376,084 $43.7 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.